QJP-29394-93883
3 vaccinations
7 coded responses
28 check-ins
3 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 750 / TX
- Registered
- 2022-07-03
- Relationship
- Child or adolescent in my care
- Guardian
- J9Q-19401-68792
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-07-01
Dose 1 — Pfizer-BioNTech
-
2022-07-03
Registered in v-safe
- 2022-07-03
- 2022-07-04
- 2022-07-05
- 2022-07-06
- 2022-07-07
-
2022-07-08
Survey response — day 7, dose 1, dependentMedDRA: Aphthous ulcer — Feeling: GoodFree text: Canker sore in mouthMedDRA releases: 2024-11 · check-in free text available
- 2022-07-16
-
2022-07-22
Dose 2 — Pfizer-BioNTech
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-27
- 2022-07-28
- 2022-07-29
-
2022-08-05
Survey response — day 14, dose 2, dependentMedDRA: Rhinorrhoea, Sneezing — Feeling: GoodFree text: Runny nose and sneezingMedDRA releases: 2024-11 · check-in free text available
- 2022-08-12
- 2022-08-19
- 2022-08-26
- 2022-09-02
-
2022-10-21
Survey response — 3 months, dose 2, dependentMedDRA: Pyrexia, Rash — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Low grade fever and rashMedDRA releases: 2024-11 · check-in free text available
- 2023-01-20
-
2023-03-23
Dose 3 — Pfizer-BioNTech
-
2023-03-29
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: FairMedDRA releases: 2024-11
-
2023-03-30
Survey response — day 7, dose 3, dependentMedDRA: Nasopharyngitis, Rhinorrhoea — Feeling: Fair · Fatigue or tirednessMedDRA releases: 2024-11
- 2023-04-06
- 2023-04-13
-
2023-04-20
Survey response — day 28, dose 3, dependentMedDRA: Pyrexia, Sinus congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-04-27
Survey response — day 35, dose 3, dependentMedDRA: Epistaxis, Vomiting — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-05-04
- 2023-06-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-01 | Pfizer-BioNTech | No |
| 2 | 2022-07-22 | Pfizer-BioNTech | No |
| 3 | 2023-03-23 | Pfizer-BioNTech | No |
Free text
Release 12 — day 7, dose 1, dependent
Systemic reaction (other): Canker sore in mouth
Release 12 — day 14, dose 2, dependent
Symptoms: Runny nose and sneezing
Release 12 — 3 months, dose 2, dependent
Symptoms: Low grade fever and rash
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Epistaxis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Aphthous ulcer | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Nasopharyngitis | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release